Jennifer Taubert to retire; Tom Cavanaugh named head of Innovative Medicine

Johnson & Johnson said Executive Vice President Jennifer Taubert will retire after more than 21 years, and Tom Cavanaugh will succeed her as Executive Vice President and Worldwide Chairman of Innovative Medicine. Cavanaugh was previously Company Group Chairman for North America in Innovative Medicine and joined the Executive Committee on September 1, 2026. The segment that Taubert led is the company's largest, at about 64% of 2025 sales.

• Taubert retiring after more than 21 years at J&J
• Cavanaugh appointed EVP, Worldwide Chairman, Innovative Medicine
• Cavanaugh joins the Executive Committee effective September 1, 2026